Funding for this research was provided by:
Foundation for the National Institutes of Health (P30CA046934)
Received: 30 June 2020
Accepted: 30 December 2020
First Online: 12 January 2021
Ethics approval & consent to participate
: This study was approved by the Colorado Multiple Institutions Review Board (Protocol 19–3103).
: Not applicable.
: SGP: none.HH: scientific advisory board for Genome Medical, InVitae Genetics, and Promega, has conducted collaborative research with Myriad Genetics Laboratories, Inc., Ambry Genetics, and InVitae Genetics, and has stock in Genome Medical.DS: none.DG: none.MC: none.FK: none.